Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Expenses (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Operating Expenses for 15 consecutive years, with $882207.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses changed 0.17% year-over-year to $882207.0, compared with a TTM value of $3.5 million through Oct 2025, down 6.73%, and an annual FY2025 reading of $3.5 million, down 6.73% over the prior year.
  • Operating Expenses was $882207.0 for Q4 2025 at Pharma-Bio Serv, down from $888139.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $6.3 million in Q4 2021 and bottomed at $860300.0 in Q1 2025.
  • Average Operating Expenses over 5 years is $1.2 million, with a median of $937479.5 recorded in 2022.
  • The sharpest move saw Operating Expenses skyrocketed 422.14% in 2021, then plummeted 85.08% in 2022.
  • Year by year, Operating Expenses stood at $6.3 million in 2021, then tumbled by 85.08% to $939683.0 in 2022, then rose by 4.46% to $981570.0 in 2023, then dropped by 10.28% to $880700.0 in 2024, then grew by 0.17% to $882207.0 in 2025.
  • Business Quant data shows Operating Expenses for PBSV at $882207.0 in Q4 2025, $888139.0 in Q3 2025, and $917048.0 in Q2 2025.